DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Use of Amnion on Partial Thickness Burns

Information source: The University of Texas Medical Branch, Galveston
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Burn

Intervention: Amnion (Biological); Amnion (Biological); Polysporin/Bacitracin/Mycostatin (Drug)

Phase: Phase 2/Phase 3

Status: Withdrawn

Sponsored by: The University of Texas Medical Branch, Galveston

Official(s) and/or principal investigator(s):
David N Herndon, MD, Principal Investigator, Affiliation: University of Texas


To determine if Amnion, used on partial thickness burn injuries would provide an improvement in rate of healing, pain control and scarring as compared to standard medical treatments.

Clinical Details

Official title: Project Title The Treatment of Partial Thickness Burns: Treated Amnion Versus Currently in Use Topical Medications

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome: Length of time to 95% healing of treated burn wounds

Secondary outcome:

Length of hospital stay

Incidence of infection

Amount of daily pain until wound is healed with different treatments.

Amount of scaring with different treatments


Minimum age: N/A. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- Partial thickness burn injury.

- >2% burn injury.

- Ages 0-100 years.

Exclusion Criteria:

- Patients not expected to survive

Locations and Contacts

Additional Information

Starting date: June 2005
Last updated: November 13, 2012

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017